219 related articles for article (PubMed ID: 24386086)
1. Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance.
Steuerwald NM; Foureau DM; Norton HJ; Zhou J; Parsons JC; Chalasani N; Fontana RJ; Watkins PB; Lee WM; Reddy KR; Stolz A; Talwalkar J; Davern T; Saha D; Bell LN; Barnhart H; Gu J; Serrano J; Bonkovsky HL
PLoS One; 2013; 8(12):e81974. PubMed ID: 24386086
[TBL] [Abstract][Full Text] [Related]
2. Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group.
Bonkovsky HL; Barnhart HX; Foureau DM; Steuerwald N; Lee WM; Gu J; Fontana RJ; Hayashi PJ; Chalasani N; Navarro VM; Odin J; Stolz A; Watkins PB; Serrano J;
PLoS One; 2018; 13(10):e0206389. PubMed ID: 30359443
[TBL] [Abstract][Full Text] [Related]
3. Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance.
Russo MW; Steuerwald N; Norton HJ; Anderson WE; Foureau D; Chalasani N; Fontana RJ; Watkins PB; Serrano J; Bonkovsky HL
Liver Int; 2017 May; 37(5):757-764. PubMed ID: 27860186
[TBL] [Abstract][Full Text] [Related]
4. Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response.
Whritenour J; Ko M; Zong Q; Wang J; Tartaro K; Schneider P; Olson E; Van Volkenburg M; Serrano J; Hayashi P; Fontana R; Chalasani N; Bonkovsky HL
J Immunotoxicol; 2017 Dec; 14(1):31-38. PubMed ID: 28121193
[TBL] [Abstract][Full Text] [Related]
5. The potential of cytokines as safety biomarkers for drug-induced liver injury.
Laverty HG; Antoine DJ; Benson C; Chaponda M; Williams D; Kevin Park B
Eur J Clin Pharmacol; 2010 Oct; 66(10):961-76. PubMed ID: 20694460
[TBL] [Abstract][Full Text] [Related]
6. Necrotic cell death and suppression of T-cell immunity characterized acute liver failure due to drug-induced liver injury.
Kakisaka K; Kataoka K; Suzuki Y; Okada Y; Yoshida Y; Kuroda H; Takikawa Y
Cytokine; 2016 Oct; 86():21-28. PubMed ID: 27442007
[TBL] [Abstract][Full Text] [Related]
7. Comparative gene and protein expression analyses of a panel of cytokines in acute and chronic drug-induced liver injury in rats.
Hanafusa H; Morikawa Y; Uehara T; Kaneto M; Ono A; Yamada H; Ohno Y; Urushidani T
Toxicology; 2014 Oct; 324():43-54. PubMed ID: 25051504
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury.
Lai R; Xiang X; Mo R; Bao R; Wang P; Guo S; Zhao G; Gui H; Wang H; Bao S; Xie Q
J Hepatol; 2015 Jul; 63(1):148-55. PubMed ID: 25681556
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury.
Xie Z; Chen E; Ouyang X; Xu X; Ma S; Ji F; Wu D; Zhang S; Zhao Y; Li L
J Proteome Res; 2019 Jun; 18(6):2514-2524. PubMed ID: 31002254
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping Study.
Cueto-Sanchez A; Niu H; Del Campo-Herrera E; Robles-Díaz M; Sanabria-Cabrera J; Ortega-Alonso A; Garcia-Cortes M; Gonzalez-Grande R; Jimenez-Perez M; Ruiz-Cabello F; Andrade RJ; Lucena MI; Stephens C
Clin Pharmacol Ther; 2021 Dec; 110(6):1604-1612. PubMed ID: 34543448
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of IL-6/IL-10/GLDH may be early recognition markers of anti-tuberculosis drugs (ATB) -induced liver injury.
Xiang HR; Li Y; Cheng X; He B; Li HM; Zhang QZ; Wang B; Peng WX
Toxicol Appl Pharmacol; 2023 Sep; 475():116635. PubMed ID: 37487937
[TBL] [Abstract][Full Text] [Related]
12. Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.
Church RJ; Kullak-Ublick GA; Aubrecht J; Bonkovsky HL; Chalasani N; Fontana RJ; Goepfert JC; Hackman F; King NMP; Kirby S; Kirby P; Marcinak J; Ormarsdottir S; Schomaker SJ; Schuppe-Koistinen I; Wolenski F; Arber N; Merz M; Sauer JM; Andrade RJ; van Bömmel F; Poynard T; Watkins PB
Hepatology; 2019 Feb; 69(2):760-773. PubMed ID: 29357190
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury.
Ghabril M; Gu J; Yoder L; Corbito L; Ringel A; Beyer CD; Vuppalanchi R; Barnhart H; Hayashi PH; Chalasani N
Gastroenterology; 2019 Nov; 157(5):1245-1252.e3. PubMed ID: 31302142
[TBL] [Abstract][Full Text] [Related]
14. Role of immune reactions in drug-induced liver injury (DILI).
Ju C; Reilly T
Drug Metab Rev; 2012 Feb; 44(1):107-15. PubMed ID: 22235834
[TBL] [Abstract][Full Text] [Related]
15. Serum proteomic profiling in patients with drug-induced liver injury.
Bell LN; Vuppalanchi R; Watkins PB; Bonkovsky HL; Serrano J; Fontana RJ; Wang M; Rochon J; Chalasani N;
Aliment Pharmacol Ther; 2012 Mar; 35(5):600-12. PubMed ID: 22403816
[TBL] [Abstract][Full Text] [Related]
16. The diagnosis and management of idiosyncratic drug-induced liver injury.
Hassan A; Fontana RJ
Liver Int; 2019 Jan; 39(1):31-41. PubMed ID: 30003672
[TBL] [Abstract][Full Text] [Related]
17. Elevated bilirubin, alkaline phosphatase at onset, and drug metabolism are associated with prolonged recovery from DILI.
Ashby K; Zhuang W; González-Jimenez A; Alvarez-Alvarez I; Lucena MI; Andrade RJ; Aithal GP; Suzuki A; Chen M
J Hepatol; 2021 Aug; 75(2):333-341. PubMed ID: 33845060
[TBL] [Abstract][Full Text] [Related]
18. Increased red cell distribution width predicts severity of drug-induced liver injury: a retrospective study.
Li X; Xu H; Gao P
Sci Rep; 2021 Jan; 11(1):773. PubMed ID: 33436893
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicants induce cytokine imbalance in response to innate immune system.
Goto S; Deguchi J; Nishio N; Nomura N; Funabashi H
J Toxicol Sci; 2015 Jun; 40(3):389-404. PubMed ID: 25972199
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a novel model to predict liver-related mortality in patients with idiosyncratic drug-induced liver injury.
Wang Y; Zou CL; Zhang J; Qiu LX; Huang YF; Zhao XY; Zou ZS; Jia JD
Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):584-593. PubMed ID: 37308361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
